{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:04:48Z","timestamp":1778940288308,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.cancergen.2012.08.004","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T02:46:24Z","timestamp":1349145984000},"page":"513-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acquired genomic copy number changes in CML patients with the Philadelphia chromosome (Ph+)"],"prefix":"10.1016","volume":"205","author":[{"given":"Xianglan","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yougmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.08.004_bib1","series-title":"The chromosomes in human cancer and leukemia","first-page":"151","year":"1990"},{"key":"10.1016\/j.cancergen.2012.08.004_bib2","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood.V85.8.2013.bloodjournal8582013","article-title":"Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia","volume":"85","author":"Sill","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.08.004_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(98)00213-1","article-title":"Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis","volume":"111","author":"Gribble","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.08.004_bib4","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1073\/pnas.0602402103","article-title":"Loss of p53 impedes the antileukemic response to BCR-ABL inhibition","volume":"103","author":"Wendel","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2012.08.004_bib5","series-title":"Prognostic markers in hematologic oncology","author":"Gorczyca","year":"2006"},{"key":"10.1016\/j.cancergen.2012.08.004_bib6","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","article-title":"Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia","volume":"95","author":"Sinclair","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.08.004_bib7","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","article-title":"Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia","volume":"98","author":"Huntly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.08.004_bib8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.leu.2402969","article-title":"Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome","volume":"17","author":"Kolomietz","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.08.004_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/gcc.10197","article-title":"A\u00a0study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression","volume":"37","author":"Lee","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.08.004_bib10","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/onc.2009.524","article-title":"Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia","volume":"29","author":"Albano","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.08.004_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-4608(01)00412-5","article-title":"Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis","volume":"128","author":"Cohen","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.08.004_bib12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood-2003-01-0123","article-title":"Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia","volume":"102","author":"Huntly","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.08.004_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF01702923","article-title":"Molecular genetic analysis of DNA obtained from fixed, air dried or paraffin embedded sources","volume":"62","author":"Gr\u00fcnewald","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2012.08.004_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng1416","article-title":"Detection of large-scale variation in the human genome","volume":"36","author":"Iafrate","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.08.004_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1098918","article-title":"Large-scale copy number polymorphism in the human genome","volume":"305","author":"Sebat","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.08.004_bib16","first-page":"952","article-title":"Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia","volume":"91","author":"Fourouclas","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2012.08.004_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00277-011-1195-2","article-title":"Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia","volume":"90","author":"Huh","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2012.08.004_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/gcc.10116","article-title":"Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients","volume":"35","author":"Storlazzi","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.08.004_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/10428190310001623900","article-title":"Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes","volume":"45","author":"Specchia","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergen.2012.08.004_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2006.06.006","article-title":"Deletion size characterization of der(9) deletions in Philadelphia-positive chronic myeloid leukemia","volume":"170","author":"Douet-Guilbert","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.08.004_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/leu.2008.154","article-title":"MicroRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia","volume":"23","author":"Chaubey","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.08.004_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/leu.2008.393","article-title":"Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia","volume":"23","author":"Gunn","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.08.004_bib23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/gcc.20303","article-title":"Genomewide screening of\u00a0DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization","volume":"45","author":"Hosoya","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.08.004_bib24","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/sj.onc.1210190","article-title":"Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization","volume":"26","author":"Strefford","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.08.004_bib25","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/gcc.20611","article-title":"Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and\/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression","volume":"47","author":"Deluche","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.08.004_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2012.08.004_bib27","first-page":"5000","article-title":"Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity","volume":"9","author":"Garc\u00eda-Manteiga","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.08.004_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ijc.20524","article-title":"Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors","volume":"112","author":"Farr\u00e9","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2012.08.004_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/15257770802145892","article-title":"Imatinib-resistant CML\u00a0cells have low ENT activity but maintain sensitivity to gemcitabine","volume":"27","author":"Zimmerman","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.cancergen.2012.08.004_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/ng.93","article-title":"A\u00a0recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures","volume":"40","author":"Sharp","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.08.004_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/0008-5472.CAN-03-2440","article-title":"Transcriptional regulation of\u00a0the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma","volume":"64","author":"Miller","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.08.004_bib32","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbadis.2007.05.006","article-title":"TRP channels in cancer","volume":"1772","author":"Prevarskaya","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cancergen.2012.08.004_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1113\/jphysiol.2006.113886","article-title":"Molecular and electrophysiological characterization of transient receptor potential ion channels in the primary murine megakaryocyte","volume":"576","author":"Carter","year":"2006","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.cancergen.2012.08.004_bib34","first-page":"200","article-title":"Malignant disorders of megakaryocytes","volume":"35","author":"Cripe","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cancergen.2012.08.004_bib35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/ijgc-00009577-200705000-00019","article-title":"Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis","volume":"17","author":"Choi","year":"2007","journal-title":"Int J Gynecol Cancer"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077621200230X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077621200230X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:09Z","timestamp":1761896289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221077621200230X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S221077621200230X"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.08.004","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired genomic copy number changes in CML patients with the Philadelphia chromosome (Ph+)","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}